Including disease relevant biomarker readouts is essential to generate actionable data. At Charles River’s site in Kuopio, Finland, our comprehensive portfolio of in vivo services are complemented by our state of the art biomarker laboratory where studies using flow cytometry, immunohistochemistry, ELISA and Luminex® assays, and autoradiography are performed to support programs in neuroscience and rare disease drug discovery.

In this video, Tuulia Huhtala, PhD, the head of Biomarker lab highlights the biomarker capabilities at the site and discusses how the biomarker services support client studies.

Related Resources